Compugen Discovers New Drug Target By: MarketMinute.com Stock News Compugen Ltd. (Nasdaq: CGEN) discovered a new drug target, CGEN-671, to treat multiple epithelial tumors sending the stock price soaring $1.23 to $5.31. Related Stocks: Compugen Ltd